ST. LOUIS, Feb. 8, 2011 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced its financial results for the quarter and year ended December 31, 2010.  The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.





















2010 Highlights







Q4





Full Year







Premium and Service Revenues (in millions)

$

1,129.5





$

4,283.8







Consolidated HBR



83.3

%





83.8

%





General & Administrative expense ratio



13.0

%





12.8

%





Diluted EPS

$

0.50





$

1.80







Cash flow from operations (in millions)

$

194.6





$

168.9































Fourth Quarter Highlights

  • Quarter-end managed care at-risk membership of 1,533,500, an increase of 75,300 members, or 5.2% year over year.
  • Premium and Service Revenues of $1,129.5 million, representing 7.5% year over year growth.
  • Health Benefits Ratio of 83.3%, compared to 83.9% in the prior year.  
  • General and Administrative expense ratio of 13.0%, compared to 12.7% in the prior year.
  • Cash flow from operations of $194.6 million.
  • Days in claims payable of 45.6.
  • Diluted earnings per share from continuing operations of $0.50 (which includes the dilution from the stock offering in early 2010), compared to $0.53 in the prior year.
  • Debt to capitalization of 29.3%, or 23.9% excluding the $80.0 million non-recourse mortgage note.


Other Events

  • During the fourth quarter of 2010, we completed the conversion of approximately 22,500 Florida members from Access Health Solutions LLC to our subsidiary, Sunshine State Health Plan, on an at-risk basis.  Additionally, in December 2010, we completed the acquisition of Citrus Health Care, Inc., a Florida Medicaid and Long-term Care health plan.  We served 194,900 at-risk members in Florida as of December 31, 2010.
  • In December 2010, we refinanced the construction loan related to our corporate headquarters development with an $80 million non-recourse mortgage loan. In January 2011, we refinanced our $300 million Revolving Credit Facility with a new $350 million unsecured Revolving Credit Facility.
  • In December 2010, Cenpatico Behavioral Health of Arizona began operating under an expanded contract to manage behavioral healthcare services in an additional four counties.  
  • In December 2010, one of our highly regarded health programs, Start Smart for Your Baby, was the recipient of the URAC/GKEN International Health Promotion Award for Community Health.   Start Smart for Your Baby also received a gold award at the 2010 Web Health Awards for its audio book and a merit award for its podcasts.
  • In January 2011, Magnolia Health Plan began operating under a new contract in Mississippi to provide managed care services to Medicaid recipients through the Mississippi Coordinated Access Network (MississippiCAN) Program.  
  • In January 2011, we entered into an agreement with Pima Health Systems in Arizona to administer their long-term care program on a non-risk basis.
  • In February 2011, Superior HealthPlan began operating under an additional STAR+PLUS ABD contract in Texas in the Dallas service area.


Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "Our team's coordinated and consistent efforts produced solid financial and operational performance in 2010, setting the stage for continued success in 2011."

The following table depicts membership in Centene's managed care organizations, by state, at December 31, 2010 and 2009:







December 31,





2010



2009

Arizona



22,400



20,700

Florida



194,900



102,600

Georgia



305,800



309,700

Indiana



215,800



208,100

Massachusetts



36,200



27,800

Ohio



160,100



150,800

South Carolina



90,300



48,600

Texas



433,100



455,100

Wisconsin



74,900



134,800

Total at-risk membership



1,533,500



1,458,200

Non-risk membership



4,200



63,700

Total



1,537,700



1,521,900

















The following table depicts membership in Centene's managed care organizations, by member category, at December 31, 2010 and 2009:







December 31,





2010



2009

Medicaid



1,177,100



1,081,400

CHIP & Foster Care



210,500



263,600

ABD & Medicare



104,600



82,800

Hybrid Programs



36,200



27,800

Long-term Care



5,100



2,600

Total at-risk membership



1,533,500



1,458,200

Non-risk membership



4,200



63,700

Total



1,537,700



1,521,900







Statement of Operations: Three Months Ended December 31, 2010

  • For the fourth quarter of 2010, Premium and Service Revenues increased 7.5% to $1,129.5 million from $1,050.8 million in the fourth quarter of 2009.  The increase was primarily driven by membership growth resulting from acquisitions in Florida and South Carolina, conversion of membership in Florida from Access to at-risk under Sunshine State Health Plan, as well as premium rate increases in 2010.  This increase was moderated by the removal of pharmacy service in two states in 2010.  These pharmacy carve outs had the effect of reducing 2010 fourth quarter revenue by approximately $52 million.
  • Consolidated HBR of 83.3% for the fourth quarter of 2010 represents a decrease of 0.6% from the comparable period in 2009.  The year over year improvement in HBR is due to rate increases, decreased costs associated with the flu and better performance in our Florida health plan.  Consolidated HBR decreased 0.9% sequentially from the third quarter of 2010.  The improvement in HBR was due to the impact of rate increases in several markets and improvements in our Florida health plan.
  • Consolidated G&A expense as a percent of premium and service revenues was 13.0% in the fourth quarter of 2010, an increase from 12.7% in the fourth quarter of 2009.  The increase in the G&A ratio between years reflects increased business expansion costs, including Mississippi, Dallas STAR+PLUS and Illinois.  
  • Earnings from continuing operations increased to $45.5 million in 2010 from $37.8 million in 2009, or 20.4% year over year.  Net earnings from continuing operations were $25.5 million, or $0.50 per diluted share in 2010 (which includes the dilution from the stock offering in early 2010), compared to $23.7 million, or $0.53 per diluted share in the fourth quarter of 2009.  


Statement of Operations: Year Ended December 31, 2010

  • For the year ended December 31, 2010, Premium and Service Revenues increased 10.5% to $4.3 billion in 2010 from $3.9 billion in 2009.  This reflects a 13.6% increase in member months, offset by reduced revenue of $185 million as a result of pharmacy carve outs in 2010.  The increase was primarily driven by membership growth resulting from acquisitions in Florida and South Carolina, conversion of membership in Florida from Access to at-risk under Sunshine State Health Plan, as well as premium rate increases in 2010.  
  • The consolidated HBR of 83.8% for 2010 represented a 0.3% increase from the 2009 consolidated HBR of 83.5%.  The increase is primarily due to the growth in our Florida health plan where we have experienced a higher HBR.  
  • G&A expenses as a percent of Premium and Service Revenues decreased to 12.8% in 2010, compared to 13.3% in 2009.  The decrease primarily reflects the leveraging of our expenses over higher revenues, partially offset by increased business expansion costs.
  • Earnings from continuing operations increased to $157.1 million in 2010 from $138.1 million in 2009, or 13.7% year over year.  Net earnings from continuing operations were $90.9 million, or $1.80 per diluted share in 2010 (which includes the dilution from the stock offering in early 2010), compared to $86.1 million, or $1.94 per diluted share in 2009.  


Balance Sheet and Cash Flow

At December 31, 2010, the Company had cash and investments of $1,073.9 million, including $1,043.0 million held by its regulated entities and $30.9 million held by its unregulated entities.  Medical claims liabilities totaled $456.8 million, representing 45.6 days in claims payable.  Total debt was $330.6 million and debt to capitalization was 29.3%.  Excluding the $80.0 million non-recourse mortgage note, our debt to capital ratio is 23.9%.  Full year 2010 cash flow from operations was $168.9 million, or 1.7 times net earnings.

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:



Days in claims payable, September 30, 2010

47.1



  Reduced time of claims processing and payment

(1.4)



  Other

(0.1)



Days in claims payable, December 31, 2010

45.6











During the fourth quarter of 2010, we experienced increased electronic claims submissions and auto-adjudication of claims which reduced the average time from claims incurred to claims paid by 1.4 days, which is reflected in the decrease in period end claims inventory from the third quarter as presented in Supplemental Financial Data included in this release.  We expect our days in claims payable to be within our targeted range of 43 to 48 days in 2011.  This may be higher from time to time as we have new plans begin operations.  

Outlook

The table below depicts the Company's annual guidance from continuing operations for 2011:







Full Year 2011







Low



High 



Premium and Service Revenues (in millions)



$   4,900



$  5,100



Diluted EPS



$    2.00



$  2.10



Consolidated HBR



84.0%



85.0%



General & Administrative expense ratio



12.0%



12.5%















Diluted Shares Outstanding (in thousands)



51,500





















Conference Call

As previously announced, the Company will host a conference call Tuesday, February 8, 2011, at 8:30 A.M. (Eastern Time) to review the financial results for the fourth quarter ended December 31, 2010, and to discuss its business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call.  Investors and other interested parties are invited to listen to the conference call by dialing 1-877-887-1134 in the U.S. and Canada; 1-412-317-0794 from abroad, or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months until 11:59 PM (Eastern Time) on Tuesday, February 7, 2012, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Wednesday, February 16, 2011, by dialing 1-877-344-7529 the U.S. and Canada, or 1-412-317-0088 from abroad, and entering access code 447292.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company's estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare.  The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.  

(Tables Follow)











CENTENE CORPORATION AND SUBSIDIARIES



CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)







December 31, 

2010



December 31,

2009



ASSETS













Current assets:













Cash and cash equivalents of continuing operations



$

433,914

$

400,951



Cash and cash equivalents of discontinued operations





252



2,801



Total cash and cash equivalents





434,166



403,752



Premium and related receivables, net of allowance for uncollectible accounts of $17 and $1,338, respectively





136,243



103,456



Short-term investments, at fair value (amortized cost $21,141 and $39,230, respectively)





21,346



39,554



Other current assets





64,154



64,866



Current assets of discontinued operations other than cash





912



4,506



Total current assets





656,821



616,134



Long-term investments, at fair value (amortized cost $585,862 and $514,256, respectively)





595,879



525,497



Restricted deposits, at fair value (amortized cost $22,755 and $20,048, respectively)





22,758



20,132



Property, software and equipment, net of accumulated depreciation of $138,629 and $103,883, respectively





326,341



230,421



Goodwill





278,051



224,587



Intangible assets, net





29,109



22,479



Other long-term assets





30,057



36,829



Long-term assets of discontinued operations





4,866



26,285



Total assets



$

1,943,882

$

1,702,364





LIABILITIES AND STOCKHOLDERS' EQUITY













Current liabilities:













Medical claims liability



$

456,765

$

470,932



Accounts payable and accrued expenses





185,218



132,001



Unearned revenue





117,344



91,644



Current portion of long-term debt





2,817



646



Current liabilities of discontinued operations





3,102



20,685



Total current liabilities





765,246



715,908



Long-term debt





327,824



307,085



Other long-term liabilities





53,378



59,561



Long-term liabilities of discontinued operations





379



383



Total liabilities





1,146,827



1,082,937

















Commitments and contingencies



























Stockholders' equity:













Common stock, $.001 par value; authorized 100,000,000 shares; and 52,172,037 issued and 49,616,824 outstanding at December 31, 2010, and 45,593,383 issued and 43,179,373 outstanding shares at December 31, 2009





52



46



Additional paid-in capital





384,206



281,806



Accumulated other comprehensive income:













Unrealized gain on investments, net of tax





6,424



7,348



Retained earnings





453,743



358,907



Treasury stock, at cost (2,555,213 and 2,414,010 shares, respectively)





(50,486)



(47,262)



Total Centene stockholders' equity





793,939



600,845



Noncontrolling interest





3,116



18,582



Total stockholders' equity





797,055



619,427



Total liabilities and stockholders' equity



$

1,943,882

$

1,702,364













CENTENE CORPORATION AND SUBSIDIARIES



CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share data)

(Unaudited)





Three Months Ended

December 31,



Year Ended

December 31,





2010





2009



2010





2009



Revenues:





























Premium

$

1,106,370





$

1,031,812



$

4,192,172





$

3,786,525



Service



23,118







19,018





91,661







91,758



Premium and service revenues



1,129,488







1,050,830





4,283,833







3,878,283



Premium tax



51,481







41,896





164,490







224,581



Total revenues



1,180,969







1,092,726





4,448,323







4,102,864



Expenses:





























Medical costs



922,070







865,415





3,514,394







3,163,523



Cost of services



16,414







14,425





63,919







60,789



General and administrative expenses



146,751







133,005





547,823







514,529



Premium tax



50,233







42,103





165,118







225,888



Total operating expenses



1,135,468







1,054,948





4,291,254







3,964,729



Earnings from operations



45,501







37,778





157,069







138,135



Other income (expense):





























Investment and other income



3,293







3,910





15,205







15,691



Interest expense



(5,452)







(4,108)





(17,992)







(16,318)



Earnings from continuing operations, before income tax expense



43,342







37,580





154,282







137,508



Income tax expense



16,958







13,781





59,900







48,841



Earnings from continuing operations, net of income tax expense



26,384







23,799





94,382







88,667



Discontinued operations, net of income tax expense (benefit)     of $12, $(56), $4,388 and $(1,204), respectively



(65)







(28)





3,889







(2,422)



Net earnings



26,319







23,771





98,271







86,245



Noncontrolling interest



920







56





3,435







2,574



Net earnings attributable to Centene Corporation

$

25,399





$

23,715



$

94,836





$

83,671

































Amounts attributable to Centene Corporation common shareholders:





























Earnings from continuing operations, net of income tax expense

$

25,464





$

23,743



$

90,947





$

86,093



Discontinued operations, net of income tax (benefit) expense



(65)







(28)





3,889







(2,422)



Net earnings

$

25,399





$

23,715



$

94,836





$

83,671

































Net earnings (loss) per share attributable to Centene Corporation:





























Basic:





























Continuing operations

$

0.52





$

0.55



$

1.87





$

2.00



Discontinued operations



—







—





0.08







(0.06)



Earnings per common share

$

0.52





$

0.55



$

1.95





$

1.94



Diluted:





























Continuing operations

$

0.50





$

0.53



$

1.80





$

1.94



Discontinued operations



—







—





0.08







(0.05)



Earnings per common share

$

0.50





$

0.53



$

1.88





$

1.89

































Weighted average number of shares outstanding:





























Basic



49,356,768







43,068,502





48,754,947







43,034,791



Diluted



51,205,720







44,513,679





50,447,888







44,316,467













CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)







Year Ended December 31,







2010





2009



Cash flows from operating activities:

















Net earnings



$

98,271





$

86,245



Adjustments to reconcile net earnings to net cash provided by operating activities:

















Depreciation and amortization





52,000







44,004



Stock compensation expense





13,874







14,634



(Gain) loss on sale of investments, net





(6,337)







(141)



(Gain) on sale of UHP





(8,201)







—



Impairment loss





5,531







—



Deferred income taxes





10,317







3,696



Changes in assets and liabilities:

















Premium and related receivables





(23,359)







2,379



Other current assets





(3,240)







(1,263)



Other assets





(2,028)







9



Medical claims liability





(30,421)







79,000



Unearned revenue





25,700







78,345



Accounts payable and accrued expenses





37,398







(60,915)



Other operating activities





(573)







2,202



Net cash provided by operating activities





168,932







248,195



Cash flows from investing activities:

















Capital expenditures





(63,304)







(23,721)



Capital expenditures of Centene Center LLC





(55,252)







(59,392)



Purchase of investments





(615,506)







(791,194)



Sales and maturities of investments





570,423







642,783



Proceeds from asset sales





13,420







—



Investments in acquisitions, net of cash acquired, and investment in equity method investee





(60,388)







(38,563)



Net cash used in investing activities





(210,607)







(270,087)



Cash flows from financing activities:

















Proceeds from exercise of stock options





3,419







2,365



Proceeds from borrowings





218,538







659,059



Proceeds from stock offering





104,534







—



Payment of long-term debt





(195,728)







(616,219)



Purchase of noncontrolling interest





(48,257)







—



Distributions (to) from noncontrolling interest





(7,387)







8,049



Excess tax benefits from stock compensation





963







53



Common stock repurchases





(3,224)







(6,304)



Debt issue costs





(769)







(458)



Net cash provided by financing activities





72,089







46,545



Net increase in cash and cash equivalents





30,414







24,653



Cash and cash equivalents, beginning of period





403,752







379,099



Cash and cash equivalents, end of period



$

434,166





$

403,752





















Supplemental disclosures of cash flow information:

















Interest paid



$

17,296





$

15,428



Income taxes paid



$

53,938





$

52,928





















Supplemental disclosure of non-cash investing and financing activities:

















Contribution from noncontrolling interest



$

306





$

5,875



Capital expenditures



$

8,720





$

(1,476)













CENTENE CORPORATION



CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA





Q4



Q3



Q2



Q1



Q4



2010



2010



2010



2010



2009

MEMBERSHIP



















Managed Care:



















Arizona                           

22,400



22,300



22,100



21,700



20,700

Florida                            

194,900



116,300



113,100



105,900



102,600

Georgia                           

305,800



300,900



295,600



301,000



309,700

Indiana                            

215,800



213,300



212,700



211,400



208,100

Massachusetts                     

36,200



34,400



30,100



26,900



27,800

Ohio                              

160,100



161,800



159,300



156,000



150,800

South Carolina                      

90,300



90,600



92,600



53,900



48,600

Texas                             

433,100



428,100



475,500



459,600



455,100

Wisconsin                         

74,900



106,100



133,600



134,900



134,800

Total at-risk membership        

1,533,500



1,473,800



1,534,600



1,471,300



1,458,200

Non-risk membership                 

4,200



35,900



50,900



62,200



63,700

TOTAL                     

1,537,700



1,509,700



1,585,500



1,533,500



1,521,900





















Medicaid                           

1,177,100



1,122,800



1,135,500



1,088,300



1,081,400

CHIP & Foster Care                  

210,500



219,100



272,400



266,300



263,600

ABD & Medicare                     

104,600



94,500



93,800



87,100



82,800

Hybrid Programs                    

36,200



34,400



30,100



26,900



27,800

Long-term Care                     

5,100



3,000



2,800



2,700



2,600

Total at-risk membership        

1,533,500



1,473,800



1,534,600



1,471,300



1,458,200

Non-risk membership                 

4,200



35,900



50,900



62,200



63,700

TOTAL                     

1,537,700



1,509,700



1,585,500



1,533,500



1,521,900





















Specialty Services (a):



















Cenpatico Behavioral Health



















Arizona                           

174,600



121,300



119,700



119,300



120,100

Kansas                           

39,200



39,800



39,100



39,800



41,400

TOTAL                     

213,800



161,100



158,800



159,100



161,500





















(a) Includes external membership only.





































REVENUE PER MEMBER PER MONTH (b)

$

239.66



$

224.62



$

218.40



$

219.90(c)



$

233.66





















CLAIMS(b)



















Period-end inventory                 

434,900



469,000



480,400



341,400



423,400

Average inventory                  

304,700



307,500



306,900



283,900



279,000

Period-end inventory per member       

0.28



0.32



0.31



0.23



0.29

(b) Revenue per member and claims information are presented for the Managed Care at-risk members.

(c) Reduction in revenue per member per month is a result of the pharmacy carve-outs in 2010.















Q4



Q3



Q2



Q1



Q4



2010



2010



2010



2010



2009





















DAYS IN CLAIMS PAYABLE



















Medical                           

44.5



46.0



47.2



46.6



48.1

Pharmacy                         

1.1



1.1



1.0



1.1



2.0

TOTAL                     

45.6



47.1



48.2



47.7



50.1

Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.





















CASH AND INVESTMENTS (in millions)

















Regulated                         

$

1,043.0



$

895.4



$

813.0



$

917.9



$

949.9

Unregulated                        



30.9





32.7





39.4





51.3





36.2

TOTAL                     

$

1,073.9



$

928.1



$

852.4



$

969.2



$

986.1





















DEBT TO CAPITALIZATION

29.3%



24.7%



24.5%



23.7%



33.2%

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT (d)

23.9%

















Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).  

(d) The non-recourse debt represents our mortgage note payable of $80.0 million at December 31, 2010.











Operating Ratios:





Three Months Ended

December 31,



Year Ended

December 31,



2010





2009



2010





2009

Health Benefits Ratios:



























     Medicaid and CHIP

82.4

%





85.3

%



83.6

%





84.6

%

    ABD and Medicare

86.8







79.9





85.0







81.1



    Specialty Services

83.4







81.8





83.4







80.2



        Total

83.3







83.9





83.8







83.5































Total General & Administrative Expense Ratio

13.0

%





12.7

%



12.8

%





13.3

%











MEDICAL CLAIMS LIABILITY (In thousands)

The changes in medical claims liability are summarized as follows:



Balance, December 31, 2009

$

470,932



Incurred related to:







Current period



3,582,463



Prior period



(68,069)



Total incurred



3,514,394



Paid related to:







Current period



3,133,527



Prior period



395,034



Total paid



3,528,561



Balance, December 31, 2010

$

456,765











Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability.  Any reduction in the "Incurred related to:  Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period."  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

The amount of the "Incurred related to: Prior period" above includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, increased receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to December 31, 2009.

SOURCE Centene Corporation

Copyright 2011 PR Newswire

Centene (NYSE:CNC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Centene Charts.
Centene (NYSE:CNC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Centene Charts.